What type of study is this?

This is a Systematic Review study.

December 8, 2025BloodOpen Access

Other cancers in patients with chronic lymphocytic leukemia/SMALL lymphocytic lymphoma

View Full Paper

Ask AI

Bookmark

Authors

HMHelen MaUniversity of California, Irvine PGPankaj GuptaUniversity of California, Irvine LRLindsey E. RoekerMayo Clinic

Discussion

Member takes

Implication

Analysis reveals that targeted therapy increases the risk of other cancers in chronic lymphocytic leukemia patients, highlighting the need for careful monitoring.

Key Points

Approximately 10% of newly diagnosed patients with chronic lymphocytic leukemia developed other cancers within five years.
Targeted therapy was linked to a 40% higher occurrence of other cancers compared to those without therapy.
Assessment using clinical databases examined the relationship between treatment types and cancer risk.
Findings suggest increased surveillance for patients undergoing chemoimmunotherapy and targeted treatments may be necessary.

Cite This Study

Ma et al. (2025) studied this question.

synapsesocial.com/papers/69362f3d4fa91c937236d4e6 https://doi.org/10.1182/blood-2025-4529

View Full Paper

Ask AI

Bookmark

Implication

Analysis reveals that targeted therapy increases the risk of other cancers in chronic lymphocytic leukemia patients, highlighting the need for careful monitoring.

Other cancers in patients with chronic lymphocytic leukemia/SMALL lymphocytic lymphoma

Discussion

Member takes

Implication

Key Points

Cite This Study

Other cancers in patients with chronic lymphocytic leukemia/SMALL lymphocytic lymphoma

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider